| Before administration | 23 weeks after administration | Stimulators | ||
---|---|---|---|---|---|
 | Control | Germanium biotite | Control | Germanium biotite | |
CD79a+ | 8.40% (±0.17) | 7.90% (±0.14) | 6.70% (±0.53) | 4.70% (±1.01) | LPS |
CD3+ | 59.50% (±0.49) | 57.80% (±0.53) | 93.50% (±0.04) | 93.10% (±0.28) | ConA |
CD4+ | 14.10% (±0.72) | 13.00% (±0.22) | 15.40% (±0.58) | 23.80% (±0.52)** | ConA |
CD8+ | 12.50% (±0.74) | 10.40% (±1.30) | 14.30% (±1.40) | 10.20% (±1.21) | ConA |
MHC I+, II+ | 43.00% (±0.45) | 37.50% (±0.12) | 8.80% (±0.17) | 10.20% (±0.15)** | ConA |